secwatch.observer — SEC 8-K summary
======================================

Issuer:     GoodRx Holdings, Inc. (GDRX)
CIK:        0001809519
Form:       8-K
Filed at:   2025-11-04T23:59:59+00:00
Accession:  0001809519-25-000141
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

GoodRx Q3 revenue $196M, net income $1.1M; raises manufacturer solutions outlook to ~35% growth
--------------------------------------------------------------------------------

- Revenue of $196.0M; net income $1.1M (0.6% margin).
- Adjusted EBITDA $66.3M (33.8% margin); Adjusted Net Income $28.8M (14.7% margin).
- Raises Pharma Manufacturer Solutions revenue growth outlook to ~35% YoY for FY2025; maintains total revenue and adjusted EBITDA guidance.
- Net cash from operations of $76.0M in Q3 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1809519/000180951925000141/0001809519-25-000141-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1809519/000180951925000141/gdrx-20251104.htm
  HTML page:      https://secwatch.observer/filing/0001809519-25-000141

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer